New COVID-19 tests approval from FDA
| US FDA emergency use authorisations for Covid-19 tests | |||||
|---|---|---|---|---|---|
| Date of EUA | Company | Test | Instrument | Turnaround time | 1-day share price move |
| March 13 | Thermo Fisher Scientific | TaqPath Covid-19 Combo Kit | Applied Biosystems 7500 | 4hr | 5% |
| March 13 | Roche Molecular Systems | Cobas Sars-CoV-2 test | Cobas 6800 and 8800 | 3.5hr | 13% |
| Note: excludes non-commercially-developed tests. Source: FDA and company communications. | |||||
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-thermo-fisher